1 Haematological Neoplasia: Leukemias - Acute & Chronic Lymphomas - Hodgkins & Non-Hodgkins (T cell,...
Transcript of 1 Haematological Neoplasia: Leukemias - Acute & Chronic Lymphomas - Hodgkins & Non-Hodgkins (T cell,...
1
Haematological Neoplasia:
Leukemias - Acute & Chronic Lymphomas - Hodgkins & Non-Hodgkins
(T cell, B cell, histiocytic & others) Premalignant Conditions: Myeloproliferative syndromes (MPS) Myelodysplastic syndromes (MDS)
Lymphomas
3
Introduction:
Neoplastic lymphoid proliferation Two types – Hodgkins & Non-Hodgkins. Fever, lymphadenopathy, Immunodeficiency / autoimmune syndrome Viral, genetic, unknown etiology. Lack of programmed cell death - Apoptosis
4
Lymphoma’sWhere They Begin
Lymphomas are a cancer of the lymphatic system
– Lymphatic vessels– Lymph nodes
(underarms, groin, neck, spleen, tonsils and bone marrow)
5
Lymphoma’sWhere They Begin
The Lymphatic system is our bodies main fight against infection
Lymphocytes (B-cell and T-cell)– Carried through our lymphatic system and help our
bodies fight infection– Lymphocytes are carried through the lymph vessels
as well as the blood stream, so cancer can start in nodes and spread anywhere throughout the body.
6
Lymphatic System
7
Lymphoma Row of enlarged lymph nodes
Lymphoma - Gross
Lymphoma Intestine
Lymphoma Intestine
Mediastinal Lymphnodes-NHL
Hodgkins Lymphoma (HL)
13
Hodgkin’s Disease
Is a malignant lymphoma characterized by the presence of atypical, multinucleated giant cell (Reed-Sternberg cell)
The disease is slightly more common in men Most patients have asymptomatic lymphadenopathy
at the time of diagnosis– The initial site of nodal involvement is:
Cervical (65-80%) Axillary (10-15%) Inguinal (6-12%)
14
Reed-Sternberg Cell
15
Hodgkins lymphoma
16
Hodgkins lymphoma cells
17
Hodgkins Lymphoma
18
Causes/Risk Factors
The exact cause of Hodgkin’s disease is unknown. Also, a virus called Epstein-Barr may be involved
with an increased risk of Hodgkin’s. Also, Agent Orange, used during the Vietnam War is
linked with the development of Hodgkin’s. Siblings of a Hodgkin’s victim are more at risk for
developing the disease. It is more common for men to have the disease. Hodgkin’s occurs most often in those between 15
and 34 or over the age of 55.
19
Classification of Hodgkin’s Disease
Treatment depends on – The anatomic distribution of the disease and the
presence or absence of specific symptoms– The stage of the disease– The histopathologic subtype
20
Classification of Hodgkin’s Disease
The Rye classification– Based on four histopathologic subtypes
Lymphocytes predominanceNodular sclerosisMixed cellularityLymphocytes depletion
21
Classification of Hodgkin’s Disease
Histopathologic diagnosis– Is made by lymph node biopsy– Nodes from the lower cervical or axillary areas provide the
best tissue for evaluation
Ann Arbor staging classification– A classification based on anatomic distribution of the
disease Stage I disease – Stage IV disease
22
23
Splenic Involvement
The probability of splenic involvement increases with increasing spleen size
The absence of splenomegaly does not exclude splenic involvement
Upon gross examination of the spleen a grayish white nodule ranging from several millimeters to several centimeters is apparent with Hodgkin’s disease
Liver involvement with Hodgkin’s disease rarely occurs in the absence of splenic disease
24
Classifications
Classic Hodgkin’s divisions– Nodular Sclerosing– Mixed Cellularity– Lymphocyte rich– Lymphocyte depleted
25
Nodular Sclerosing
>60% of cases Connective tissue RS cells Lacunar cells other cells
26
Mixed Cellularity
15 – 30% cases Mixed cells
– Lymphocytes– Histocytes– Eosinophils– Plasma cells– RS cells– Variants– +Necrosis
27
Lymphocyte rich
<5% cases Large numbers of Lymphocytes May suppress other cells RS cells Not to be confused with LP Hodgkin’s
28
Lymphocyte depleted
<1% cases Lymphocytes rare RS cells predominate
29
Symptoms & Presentation
Swollen, painful lymph nodes Fatigue, etc. Generalized iching Appetite, weight loss Neck %/or back pain Hair loss Night sweats
30
Hodgkin’s Disease
Symptoms such as fever, night sweats, weight loss and pruritus are indicative of widespread involvement and are unfavorable prognostic signs
– A typical fever pattern is a high-temperature alternating for a few days with an afebrile period
Many patients have a mild normochromic, normocytic anemia
– 1/3 have a leukocytosis due to a neutrophil increase– Eosinophilia is frequently present
31
Prognosis
Staging Nodular or Diffuse Anatomical Staging
– Stage I- one region– Stage II- two regions, same side diaphragm– Stage III- two regions, both sides of diaph– Stage IV- spread outside of lymph system
I & II- >10 years III & IV - < 6 years
32
Current Treatment of Hodgkin’s Disease
Integrates radiation therapy and combination chemotherapy to achieve the maximum potential for cure
Untreated Hodgkin’s has a five-year survival rate of 5%
The Stanford experience-patients at all stages have survival rate of 86%
– Patients in stage IV have a generally poor prognosis
Non-Hodgkins Lymphoma (NHL)
34
NON- Hodgkin’s Lymphoma
Absence of Reed-Sternberg Cells May result from damage to DNA that controls
growth of cells in immune system Increased incidence in immunodeficiency
35
Associated with Non-H lymphoma
SLE Celiac Disease AIDS Organ transplant patients Rheumatoid Arthritis
36
Causes and Risk Factors
The Exact causes are still unknown– Higher risk for individuals who:
Exposed to chemicals such as pesticides or solvents Infected w/ Epstein-Barr Virus Family history of NHL (although no hereditary pattern
has been established) Infected w/ Human Immunodeficiency Virus (HIV)
37
Classifications
Based on cell type and location(s) Non symptomatic -> Aggressive
– Worst prognosis < 1 year
38
Non-Hodgkin’s Lymphoma (NHL)
A diverse group of primary malignancies of lymphoreticular tissue
The clinical course and natural history is more variable than Hodgkin’s disease
The pattern of spread is irregular and more patients have leukemic features
Current histologic classifications utilize electron microscopic morphology, histochemical studies and selected cell surface antigens.
– For our purposes NHL is classified according to nodular (favorable) and diffuse (unfavorable) types
39
NHL
In contrast to Hodgkin’s disease, about two-thirds of patients initially have asymptomatic lymphadenopathy
In addition to peripheral and mediastinal lymphadenopathy NHL is commonly found initially as an abdominal mass or as hepatic or splenic enlargement
Fever, weight loss and night sweats are frequently present
The median age at diagnosis is 50 No sex preference is noted
40
NHL
Patients below 35 or over 65 are more likely to have diffuse histology
As with Hodgkin’s, chemotherapy and / or radiation therapy are the primary forms of treatment
Staging laparotomy is seldom required Significant therapeutic benefit can be achieved by
splenectomy in 80-90 % of patients with advanced lymphomas (including Hodgkin’s disease)
41
Classification
Usually classified by how the cells look under a microscope and how quickly they grow and spread– Aggressive lymphomas (high-grade lymphomas)
– Indolent Lymphomas (low-grade lymphomas)
42
Classification of Malignant Lymphomas
Low Grade: small lymphoid cells, nodular growth
Intermediate Grade: large cells, follicular and diffuse patterns
High Grade: immunoblastic, lymphoblastic, Burkitt’s disease
T-cell lymphomas: peripheral, cutaneous
43
Non-Hodgkin’s LymphomaStaging
Stage is the term used to describe the extent of tumor that has spread through the body( I and II are localized where as III and IV are advanced.
Each stage is then divided into categories A, B, and E
– A: No systemic symptoms– B: Systemic Symptoms such as fever, night sweats and
weight loss– E: Spreading of disease from lymph node to another organ
44
Staging
45
Non-Hodgkin’s Lymphoma
Two main types of Non-Hodgkin’s Lymphoma:
B-Cell and T-Cell Lymphomas– B-Cell lymphomas (80%)– T-Cell lymphomas (15%)
46
NHL – Classification:
According to cell type – T cell, B cell, Histiocytic & Misc. NHL
According to Clinical grade – Low grade, Intermediate & High grade NHL.
Histopathological– Diffuse/Follicular NHL, – Small, Intermediate & Large cell NHL
Ex: Lennert’s lymphoma is a low grade Tcell NHL. Burkitt’s lymphoma is a high grade B cell NHL
47
Kiel Classification of NHL
B Cell NHL:– Low Grade: lymphocytic, plasmacytic, centrocytic,
mixed centrocytic centroblastic.– High Grade: Centroblastic, Immunoblastic, Burkitts,
lymphoblastic.
T Cell NHL:– Low Grade: lymphocytic, mycosis, Lennerts– High Grade: immunoblastic, lymphoblastic etc.
Rare types:
48
NCI – Working Formulation
Low-grade NHL:– Small lymphocytic– Follicular small cleaved
Intermediate-grade NHL:– Follicular large cell– Diffuse small cleaved
High-grade NHL:– Immunoblastic– Lymphoblastic
Miscellaneous: Histiocytic, Mycosis etc.
Diffuse - & - Follicular
NHL- Histologic types
Small – Intermed. – Large
NHL- Histologic typesNHL- Histologic types
Staging of Lymphoma
Lymphoma spread to Spleen
Lymphoma spread to Spleen
Laboratory Diagnosis:
55
Laboratory Diagnosis:
Haematological: – Normocytic normochromic anemia, High ESR*– Leucocytosis, Eosinophilia, lymphopenia– Leukoerythroblastic picture - BM infiltration*
Bone marrow:– Normal, or late involvement.– Trephine biopsy- diffuse or follicular infiltration
Biochemical:– High serum LDH – poor prognosis– Hypercalcemia, Alkaline phosphatase, Uric acid.– Serum transaminases & Bilirubin – Liver
56
Laboratory Diagnosis:
Immunological:– Monoclonal gammopathy –B cell NHL, Myeloma– Low normal gammaglobulins– Autoimmune hemolytic anemia – auto ab.
Karyotypic/Genetic:– t(14;18) – B cell follicular (14* heavy chain)– t(11;14) – diffuse NHL
57
Diagnosis
X-Rays CT scans Magnetic Resonance Imaging (MRI) Biopsy Lymphangiogram
– Pictures of the lymphatic system taken w/ x-ray after a special dye is injected to illuminate lymph nodes and vessels
58
Treatment
Non-Hodgkin’s Lymphoma is usually treated by a team of physicians including hematologists, medical oncologists and a radiation oncologist.
In some cases such as for Indolent lymphomas, the Doctor may wait to start treatment until the patient starts showing symptoms, known as “watchful waiting”
59
Treatment Options
Chemotherapy Radiation Bone Marrow Transplantation Surgery Bortezomib (Velcade) Immunotherapy
Using the bodies own immune system combined with material made in a lab.
60
Treatment:
Staging & grading
Chemotherapy – CHOP, MCHOP.. Radiotherapy – Local/regional/TBI Combination – Intensive Chemo/Radio-TBI with Autologous bone marrow rescue.
61
Survival Rates
Survival Rates vary widely by cell type and staging.
– 1 Year Survival Rate: 77%
– 5 Year Survival Rate: 56%
– 10 Year Survival Rate: 42%
Burkitt’s Lymphoma
63
Burkitt’s Lymphoma
Unusual, B-Lymphoblastic high grade Young african children, jaw bones Isolated histiocytes, starry sky pattern EBV infection related. t(8;14) Chemotherapy – good response But relapse usual, 30% cure.
Burkitt’s Lymphoma
Burkitt’s Lymphoma L.N.
66
Lymphoma Summary:
Solid malignancy of lymphoid tissue. Lymphadenopathy, fever, anemia. Hodgkins & Non-Hodgkins (NHL) types. RS-Cells, eosinophilia – Hodgkins. Low-grade, Intermediate & High grade. Blood, Biochemical, BM, LN - biopsy Immunological & Genetic tests. Chemotherapy, Radiotherapy, combination